Ibáñez-Cabellos José Santiago, Sandoval Juan, Pallardó Federico V, García-Giménez José Luis, Mena-Molla Salvador
Department of Physiology, Faculty of Pharmacy, University of Valencia, 46100 Burjassot, Spain.
EpiDisease S.L. (Spin-Off from the CIBER-ISCIII), Parc Científic de la Universitat de Valencia, 46980 Paterna, Spain.
Int J Mol Sci. 2025 Apr 4;26(7):3392. doi: 10.3390/ijms26073392.
Significant deviations between chronological and biological age can signal the early risk of chronic diseases, driving the need for tools that accurately determine biological age. While DNA methylation-based clocks have demonstrated strong predictive power for biological aging determination, their clinical application is limited by several barriers including high costs, the need to analyze hundreds of methylation sites using sophisticated platforms and the lack of standardized measurement tools and protocols. In this study, we developed a multivariate linear model using the analysis of eight CpGs within the promoter region of the very long chain fatty acid elongase 2 gene (). The model generated predicts biological age with a mean absolute error (MAE) of 5.04, providing a simplified, cost-effective alternative to more complex methylation-based clocks. Additionally, we identified sex-specific biological clocks, achieving MAEs of 4.37 for males and 5.38 for females, highlighting sex-related molecular differences in the methylation of this gene during aging. Our minimal CpG-based clock offers a practical solution for estimating biological age, with potential applications in clinical practice for assessing age-related disease risks and providing personalized healthcare interventions.
实足年龄与生物年龄之间的显著偏差可能预示着慢性疾病的早期风险,这促使人们需要能够准确确定生物年龄的工具。虽然基于DNA甲基化的时钟在确定生物衰老方面已显示出强大的预测能力,但其临床应用受到多种障碍的限制,包括成本高昂、需要使用复杂平台分析数百个甲基化位点,以及缺乏标准化的测量工具和方案。在本研究中,我们通过分析超长链脂肪酸延长酶2基因()启动子区域内的8个CpG位点,开发了一种多变量线性模型。所生成的模型预测生物年龄的平均绝对误差(MAE)为5.04,为更复杂的基于甲基化的时钟提供了一种简化、经济高效的替代方案。此外,我们还确定了性别特异性的生物钟,男性的MAE为4.37,女性为5.38,突出了衰老过程中该基因甲基化的性别相关分子差异。我们基于最少CpG位点的时钟为估计生物年龄提供了一个实用的解决方案,在临床实践中具有评估与年龄相关疾病风险和提供个性化医疗干预的潜在应用价值。